-
2141
-
2142
-
2143
-
2144
-
2145
Impact of a pharmaceutical care service for patients with rheumatoid arthritis using a customised mobile device (the PROUD trial): study protocol for a randomised controlled trial
Published 2022-06-01“…The secondary outcomes will be the changes in the following: scores of the Korean version of the Compliance Questionnaire-Rheumatology and medication knowledge at 3 and 6 months compared with baseline; scores of the Korean version of the Pharmacy Service Questionnaire at 6 months compared with baseline; clinical parameters such as erythrocyte sedimentation rate, C reactive protein level, and pain score at 3 and 6 months compared with baseline; frequency of acute care utilisation over 6 months. …”
Get full text
Article -
2146
Pharmacometabolomics Enables Real-World Drug Metabolism Sciences
Published 2025-01-01Get full text
Article -
2147
Neurocognitive function and health-related quality of life among glioblastoma patients: A prospective study
Published 2025-01-01Get full text
Article -
2148
-
2149
-
2150
Arab representation in Israeli healthcare professions: achievements, challenges and opportunities
Published 2025-02-01“…In medicine, dentistry, and pharmacy, many of the licensed Arab health professionals had studied outside of Israel; this phenomenon also exists for nursing but is less widespread there. …”
Get full text
Article -
2151
-
2152
-
2153
Evaluating the Nolla Method for Dental Age Estimation in Children from Northwestern Romania
Published 2025-01-01Get full text
Article -
2154
Th1/Th2 Dichotomy in Obese Women with Gestational Diabetes and Their Macrosomic Babies
Published 2018-01-01Get full text
Article -
2155
Antihypertensive drug-related problems in Vietnamese ambulatory care
Published 2025-01-01Get full text
Article -
2156
In-hospital costs of diabetic foot infection at a national referral hospital in Jakarta, Indonesia
Published 2025-01-01Get full text
Article -
2157
Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review
Published 2025-01-01“…Juan Pan,1,* Zuyi Li,1,* Chao Ye,2 Xiaojuan Zhang,1 Qiongliang Yang,1 Xu Zhang,1 Ya Zhou,3 Jianjun Zhang2 1Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, Changsha, Hunan, 410300, People’s Republic of China; 2Department of Pharmacy, Guangdong Provincial second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, Guangdong, 510095, People’s Republic of China; 3Department of Pharmacy, People’s Hospital of Ningxiang City Affiliated to Hunan University of Chinese Medicine, Changsha, Hunan, 410600, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chao Ye, Department of Pharmacy, Guangdong Provincial second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), No. 60, Hengfu Road, Guangzhou, Guangdong, 510095, People’s Republic of China, Email yechao1234256@163.comObjective: Mesalazine is a widely used medication for treating mild to moderate inflammatory bowel disease (IBD). …”
Get full text
Article -
2158
-
2159
-
2160